The BioAnaLab founders have many years of experience of research with therapeutic monoclonal antibodies and understand the issues which affect academic research groups. BioAnaLab is enthusiastic to work with non-commercial organisations, including Universities, Government and Charitable research units who are conducting clinical trials with biopharmaceuticals, including monoclonal antibodies and vaccines. Within the European Community, legislation to implement the Directive on Good Clinical Practice (GCP) comes into effect in May 2004. This has a major impact on all clinical research, especially investigator-sponsored clinical trials. BioAnaLab can help academic groups to comply with the requirements of this legislation by providing well characterised and validated analytical tests for drug levels and immune responses.